Shares in Max Healthcare and Apollo Hospitals fell amid proposals for greater transparency and regulation of private hospital tariffs, signalling investor concerns over future margins and market dynamics in India’s healthcare sector.
Shares in Max Healthcare Institute and Apollo Hospitals Enterprise slipped on Wednesday after a parliamentary panel urged tighter controls on private hospital pricing, reviving investor concerns over billing transparency and margins in India’s listed hospital chains.
Max Healthcare fell as much as 2.13% intraday, while Apollo Hospitals dropped 1.68%, as the market weighed proposals that would force private hospitals to publish tariffs before admitting patients and introduce an immediate legal mechanism to cap room charges. The panel also called for a fast-track ombudsman to handle disputes over excessive bills and disagreements between hospitals and insurers.
The debate has broader significance because hospital pricing has long been criticised for complexity and opacity. A World Health Organization report on private healthcare charges said bills can bundle accommodation, facility fees and other items such as prostheses, while patients often face multiple charges for a single stay. It also noted that many prices sit well above public-sector levels and, in some cases, international norms.
Apollo Hospitals has previously sought to address that concern through its own pricing model. In its 2021-22 annual report, the company said it had introduced Assured Pricing Plans to reduce uncertainty around surgical costs by focusing on the value of treatment rather than a long list of inputs. The latest policy discussion now puts that approach back in the spotlight, alongside a wider push in other countries for clearer hospital pricing and better disclosure to patients and insurers.
The panel’s recommendations also extend beyond billing. It has proposed changing the GST treatment of healthcare services from exemption to zero-rating, a shift that could allow hospitals to claim input tax credit on equipment and infrastructure spending. That suggestion may appeal to providers investing heavily in expansion, but the immediate market reaction showed that investors are more focused on the risk that stricter pricing rules could limit room for revenue growth.
Disclaimer: This article is intended to inform and educate, not to recommend or endorse any financial product, investment or strategy. Please consider your own financial circumstances and seek professional advice where appropriate before making financial decisions.
